
- Get in Touch with Us
Last Updated: Apr 25, 2025 | Study Period: 2024-2030
Medical transport boxes for the secure transportation of samples. The model range MT comprises of one active transport box and five passive transport systems that cooperate with a compressor.
Medical Solutions' transport systems are perfect for frequent usage across a wide range of transport applications, even in challenging environmental conditions. Passive MT models are in compliance with the European Agreement on the International Transport of Hazardous Goods by Road (ADR), Rail (RID), Sea (IMDG), and Air (ICAO-TI/IATA-DGR).
The Global Medical Transport Boxes market accounted for $XX Billion in 2023 and is anticipated to reach $XX Billion by 2030, registering a CAGR of XX% from 2024 to 2030.
A new generation of medical transport boxes was developed by Se cop Group and B Medical Systems. With an active transport unit equipped with a cascade compressor system, SECOP and B Medical Systems hope to provide a dependable and efficient active medical cold chain solution. This device is especially designed to achieve ultra-low temperatures even in tropical ambient circumstances.
In accordance with the terms of the agreement, SECOP and B Medical Systems will work together to develop and test a number of products, utilizing SECOP's decades of expertise in effective mobile cooling compressors and B Medical Systems' skills in creating novel, dependable medical transportation boxes.
The development of several extremely temperature-sensitive vaccines, the COVID19 pandemic, the rise in the adoption of mRNA technology, and the increasing prominence of Cell & Gene Therapy (CGT), to name a few, have all contributed to an increase in the industry's demand for dependable, ultra-low temperature medical cold chain solutions.
Through an active transport unit with a cascade compressor system that has been specifically engineered to attain ultra-low temperatures even in all conditions, up to ambient temperatures of 43°C, the partners hope to provide a dependable and efficient active medical cold chain solution.
Sl no | Topic |
1 | Market Segmentation |
2 | Scope of the report |
3 | Abbreviations |
4 | Research Methodology |
5 | Executive Summary |
6 | Introduction |
7 | Insights from Industry stakeholders |
8 | Cost breakdown of Product by sub-components and average profit margin |
9 | Disruptive innovation in the Industry |
10 | Technology trends in the Industry |
11 | Consumer trends in the industry |
12 | Recent Production Milestones |
13 | Component Manufacturing in US, EU and China |
14 | COVID-19 impact on overall market |
15 | COVID-19 impact on Production of components |
16 | COVID-19 impact on Point of sale |
17 | Market Segmentation, Dynamics and Forecast by Geography, 2024-2030 |
18 | Market Segmentation, Dynamics and Forecast by Product Type, 2024-2030 |
19 | Market Segmentation, Dynamics and Forecast by Application, 2024-2030 |
20 | Market Segmentation, Dynamics and Forecast by End use, 2024-2030 |
21 | Product installation rate by OEM, 2023 |
22 | Incline/Decline in Average B-2-B selling price in past 5 years |
23 | Competition from substitute products |
24 | Gross margin and average profitability of suppliers |
25 | New product development in past 12 months |
26 | M&A in past 12 months |
27 | Growth strategy of leading players |
28 | Market share of vendors, 2023 |
29 | Company Profiles |
30 | Unmet needs and opportunity for new suppliers |
31 | Conclusion |
32 | Appendix |